Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder
August 25, 2020Massachusetts Eye and Ear, a member hospital of Mass General Brigham, is entering into an exclusive licensing agreement with Biogen to develop a potential treatment for inherited retinal degeneration due to mutations in the PRPF31 gene, which are among the most common causes for autosomal dominant retinitis pigmentosa. Inherited retinal... Read More
Kinga M. Bujakowska, PhD, Receives RPB International Research Collaborators Award
August 14, 2020Kinga M. Bujakowska, PhD, a molecular geneticist and Assistant Professor of Ophthalmology at Harvard Medical School, has been awarded the Research to Prevent Blindness 2020 RPB International Research... Read More
Genetic Links Between Glaucoma and Alzheimer’s Disease
August 14, 2020New research led by Drs. Janey Wiggs and Milica Margeta (Mass. Eye and Ear), recently published in Read More
Caitlin Collin, PhD, Awarded Knights Templar Eye Foundation Grant
August 14, 2020Mass. Eye and Ear postdoctoral research fellow Caitlin Collin, PhD, was awarded a Career Starter Grant from the Knights Templar Eye Foundation. The grant will provide $70,000 of support for Dr. Collin’s research on the development of gene editing approaches for ABCA4-associated Stargardt disease. The Knights... Read More